YXE-33117-45512
4 vaccinations
6 coded responses
47 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 209 / MD
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-28
Registered in v-safe
-
2021-02-28
Dose 1 — Pfizer-BioNTech
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-14
-
2021-03-21
Dose 2 — Pfizer-BioNTech
- 2021-03-21
- 2021-03-22
-
2021-03-23
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Good · Site: PainFree text: Pain in axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Good · Site: PainFree text: Pain in axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Good · Site: PainFree text: Pain in the axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Good · Site: PainFree text: Pain in the axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: GoodFree text: Pain in axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Health check-in — day 7, dose 2Feeling: Good · Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-04
- 2021-04-11
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-06-20
- 2021-09-19
-
2021-10-29
Dose 3 — Pfizer-BioNTech
- 2021-10-29
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Hypotension — Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Low blood pressureMedDRA releases: 2024-11 · check-in free text available
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2022-01-28
- 2022-04-29
-
2022-09-21
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-30
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-12-21
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-10-29 | Pfizer-BioNTech | No |
| 4 | 2022-09-21 | Pfizer-BioNTech | Flu |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Pain in axilla
Systemic reaction (other): Pain in axilla
Systemic reaction (other): Pain in the axilla
Systemic reaction (other): Pain in the axilla
Systemic reaction (other): Pain in axilla
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Low blood pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Hypotension | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release